SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 6th, 2020 • Aeterna Zentaris Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 6th, 2020 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 1, 2020, between Aeterna Zentaris Inc., a corporation incorporated under the laws of Canada (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
STRICTLY CONFIDENTIAL Aeterna Zentaris Inc. Summerville, South Carolina USA 29486 Attn: Klaus Paulini, Chief Executive Officer Dear Mr. Paulini:Engagement Letter • July 6th, 2020 • Aeterna Zentaris Inc. • Pharmaceutical preparations
Contract Type FiledJuly 6th, 2020 Company IndustryReference is made to the engagement letter (the “Engagement Letter”), dated as of June 10, 2020, by and between Aeterna Zentaris Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which Wainwright shall serve, among other things, as the exclusive agent in any Offering of Securities of the Company during the “Term” (as defined in the Engagement Letter). Defined terms used herein but not defined herein shall have the meanings given to such terms in the Engagement Letter.